Tenax Therapeutics, Inc. announced that James Mitchum has been nominated to be elected to the company's Board of Directors at the annual meeting of stockholders scheduled for September 15, 2015. Mr. Mitchum has served as the chief executive officer of Heart to Heart International since September 2014. From 2009 to July 2012, Mr. Mitchum served as president of the Americas for EUSA Pharma (USA), Inc. Previously, he served as President And Chief Executive Officer of Enturia, Inc. From 2003 to 2005, Mr. Mitchum served as the President And Chief Executive Officer of Sanofi-Aventis Group Japan, and he was Chief Executive for Aventis Pharma UK from 2000 through 2002.

Mr. Mitchum currently serves as a director for NephroGenex Inc.